BIIB054

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	9

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

trials per page:

Showing 1 to 9 of 9 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03716570 (ClinicalTrials.gov)	March 12, 2019	22/10/2018	A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB054in Japane ...	A Multicenter, Blinded, Placebo-Controlled, Randomized, Single and Multiple-Ascending Dose Study of ...	Parkinson's Disease	Drug: BIIB054;Drug: Placebo	Biogen	NULL	Terminated	40 Years	80 Years	All	24	Phase 1	Japan
2	EUCTR2016-004610-95-DE (EUCTR)	01/10/2018	27/02/2018	Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054in Participants wi ...	A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study, with an Active-Treatment Dose-Bli ...	Parkinson's Disease MedDRA version: 20.0;Level: PT;Classification code 10061536;Term: Parkinson's di ...	Product Code: BIIB054 INN or Proposed INN: n/a Other descriptive name: BIIB054	Biogen Idec Research Limited	NULL	Not Recruiting			Female: yes Male: yes	357	Phase 2	France;United States;Canada;Spain;Austria;Israel;Germany;United Kingdom;Italy
3	EUCTR2016-004610-95-FR (EUCTR)	08/08/2018	01/03/2018	Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054in Participants with Parkins ...	A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study, with an Active-Treatment Dose-Bli ...	Parkinson's Disease MedDRA version: 20.0;Level: PT;Classification code 10061536;Term: Parkinson's di ...	Product Code: BIIB054 INN or Proposed INN: n/a Other descriptive name: BIIB054	Biogen Idec Research Limited	NULL	Not Recruiting			Female: yes Male: yes	311	Phase 2	United States;France;Canada;Spain;Austria;Israel;Germany;United Kingdom;Italy;Sweden
4	EUCTR2016-004610-95-ES (EUCTR)	18/05/2018	07/03/2018	Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054in Participants with Parkins ...	A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study, with an Active-Treatment Dose-Bli ...	Parkinson's Disease MedDRA version: 20.0;Level: PT;Classification code 10061536;Term: Parkinson's di ...	Product Code: BIIB054 INN or Proposed INN: n/a Other descriptive name: BIIB054	Biogen Idec Research Limited	NULL	Not Recruiting			Female: yes Male: yes	311	Phase 2	United States;France;Canada;Spain;Austria;Israel;Germany;United Kingdom;Italy;Sweden
5	EUCTR2016-004610-95-GB (EUCTR)	01/05/2018	27/12/2017	Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054in Participants wi ...	A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study, with an Active-Treatment Dose-Bli ...	Parkinson's Disease MedDRA version: 20.0;Level: PT;Classification code 10061536;Term: Parkinson's di ...	Product Code: BIIB054 INN or Proposed INN: n/a Other descriptive name: BIIB054	Biogen Idec Research Limited	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	357	Phase 2	United States;France;Canada;Spain;Austria;Israel;Germany;Italy;United Kingdom
6	EUCTR2016-004610-95-AT (EUCTR)	23/03/2018	04/01/2018	Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054in Participants wi ...	A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study, with an Active-Treatment Dose-Bli ...	Parkinson's Disease MedDRA version: 20.0;Level: PT;Classification code 10061536;Term: Parkinson's di ...	Product Code: BIIB054 INN or Proposed INN: n/a Other descriptive name: BIIB054	Biogen Idec Research Limited	NULL	Not Recruiting			Female: yes Male: yes	357	Phase 2	United States;France;Canada;Spain;Austria;Israel;Germany;United Kingdom;Italy
7	EUCTR2016-004610-95-IT (EUCTR)	22/03/2018	14/01/2021	Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054in Participants with Parkins ...	A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study, with an Active-Treatment Dose-Bli ...	Parkinson's Disease MedDRA version: 20.0;Level: PT;Classification code 10061536;Term: Parkinson's di ...	Product Name: nd Product Code: [BIIB054] INN or Proposed INN: HA 1A ANTICORPO MONOCLONALE UMANO CLASSE ...	BIOGEN IDEC RESEARCH LIMITED	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	311	Phase 2	France;United States;Canada;Spain;Austria;Australia;Israel;Germany;United Kingdom;Italy;Sweden
8	NCT03318523 (ClinicalTrials.gov)	January 10, 2018	19/10/2017	Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054in Participants Wi ...	A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study, With an Active-Treatment Dose-Bli ...	Parkinson's Disease	Drug: Placebo;Drug: BIIB054	Biogen	NULL	Terminated	40 Years	80 Years	All	357	Phase 2	United States;Austria;Canada;France;Germany;Israel;Italy;Spain;United Kingdom
9	NCT02459886 (ClinicalTrials.gov)	July 1, 2015	29/5/2015	Single-Ascending Dose Study of BIIB054 in Healthy Participants and Early Parkinson's Disease	A Phase 1 Randomized, Double-Blinded, Placebo-Controlled Single-Ascending Dose Study of the Safety, ...	Parkinson's Disease;Healthy	Drug: BIIB054;Drug: Placebo	Biogen	NULL	Completed	40 Years	80 Years	All	66	Phase 1	United States

First Previous1Next Last